Royal Bank of Canada’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $292K | Buy |
100,897
+100,843
| +186,746% | +$292K | ﹤0.01% | 4546 |
|
2025
Q1 | $0 | Sell |
54
-932
| -95% | – | ﹤0.01% | 6560 |
|
2024
Q4 | $3K | Sell |
986
-6,254
| -86% | -$19K | ﹤0.01% | 6155 |
|
2024
Q3 | $47K | Buy |
7,240
+3,273
| +83% | +$21.2K | ﹤0.01% | 5265 |
|
2024
Q2 | $29K | Buy |
3,967
+3,373
| +568% | +$24.7K | ﹤0.01% | 5518 |
|
2024
Q1 | $4K | Sell |
594
-8,207
| -93% | -$55.3K | ﹤0.01% | 6059 |
|
2023
Q4 | $40K | Buy |
8,801
+1,923
| +28% | +$8.74K | ﹤0.01% | 5548 |
|
2023
Q3 | $27K | Buy |
6,878
+4,203
| +157% | +$16.5K | ﹤0.01% | 5586 |
|
2023
Q2 | $8K | Buy |
+2,675
| New | +$8K | ﹤0.01% | 6086 |
|
2022
Q4 | – | Sell |
-42
| Closed | – | – | 6967 |
|
2022
Q3 | $0 | Buy |
+42
| New | – | ﹤0.01% | 7120 |
|
2021
Q2 | – | Sell |
-91
| Closed | -$1K | – | 7013 |
|
2021
Q1 | $1K | Sell |
91
-17
| -16% | -$187 | ﹤0.01% | 6804 |
|
2020
Q4 | $2K | Sell |
108
-20
| -16% | -$370 | ﹤0.01% | 6304 |
|
2020
Q3 | $2K | Sell |
128
-51
| -28% | -$797 | ﹤0.01% | 5827 |
|
2020
Q2 | $2K | Buy |
179
+3
| +2% | +$34 | ﹤0.01% | 5809 |
|
2020
Q1 | $1K | Buy |
176
+26
| +17% | +$148 | ﹤0.01% | 5949 |
|
2019
Q4 | $2K | Buy |
150
+59
| +65% | +$787 | ﹤0.01% | 5949 |
|
2019
Q3 | $1K | Buy |
91
+58
| +176% | +$637 | ﹤0.01% | 5794 |
|
2019
Q2 | $0 | Sell |
33
-8
| -20% | – | ﹤0.01% | 5945 |
|
2019
Q1 | $1K | Buy |
41
+8
| +24% | +$195 | ﹤0.01% | 5625 |
|
2018
Q4 | $2K | Sell |
33
-224
| -87% | -$13.6K | ﹤0.01% | 5548 |
|
2018
Q3 | $36K | Buy |
257
+32
| +14% | +$4.48K | ﹤0.01% | 4790 |
|
2018
Q2 | $28K | Sell |
225
-3,320
| -94% | -$413K | ﹤0.01% | 4819 |
|
2018
Q1 | $317K | Sell |
3,545
-13
| -0.4% | -$1.16K | ﹤0.01% | 3442 |
|
2017
Q4 | $197K | Buy |
3,558
+1
| +0% | +$55 | ﹤0.01% | 3729 |
|
2017
Q3 | $150K | Buy |
3,557
+6
| +0.2% | +$253 | ﹤0.01% | 4020 |
|
2017
Q2 | $149K | Sell |
3,551
-75
| -2% | -$3.15K | ﹤0.01% | 3844 |
|
2017
Q1 | $202K | Sell |
3,626
-68
| -2% | -$3.79K | ﹤0.01% | 3711 |
|
2016
Q4 | $141K | Buy |
3,694
+161
| +5% | +$6.15K | ﹤0.01% | 3962 |
|
2016
Q3 | $140K | Sell |
3,533
-183
| -5% | -$7.25K | ﹤0.01% | 3925 |
|
2016
Q2 | $268K | Buy |
3,716
+3,505
| +1,661% | +$253K | ﹤0.01% | 3541 |
|
2016
Q1 | $17K | Buy |
211
+103
| +95% | +$8.3K | ﹤0.01% | 4855 |
|
2015
Q4 | $8K | Sell |
108
-63
| -37% | -$4.67K | ﹤0.01% | 5270 |
|
2015
Q3 | $66K | Buy |
171
+146
| +584% | +$56.4K | ﹤0.01% | 4419 |
|
2015
Q2 | $10K | Buy |
+25
| New | +$10K | ﹤0.01% | 5548 |
|
2015
Q1 | – | Sell |
-3
| Closed | -$1K | – | 5727 |
|
2014
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 5447 |
|